The AstraZeneca SARS-CoV2 AZD1222 vaccine, which was developed at the University of Oxford, is a chimpanzee adenovirus strain which was engineered so that it could not replicate any more in humans. The team at Oxford had already begun to use this chimpanzee adenovirus vaccine technology to produce candidate vaccines against many pathogens including influenza, Zika and the Middle East Respiratory Syndrome coronavirus. (Read More)
Be the first to comment